期刊文献+

Analysis of the Utilization of Digestive System Essential Drugs in Our Hospital during the Period of 2007-- 2009 被引量:1

Analysis of the Utilization of Digestive System Essential Drugs in Our Hospital during the Period of 2007-- 2009
原文传递
导出
摘要 目的:了解我院消化系统基本药物的应用情况及趋势,为临床合理用药提供参考。方法:采用限定日剂量方法,对我院2007-2009年消化系统基本药物的应用数量、销售金额、用药频度、日用药费用等进行统计、分析。结果:我院消化系统药物销售金额呈逐年上升趋势,而其基本药物销售金额呈下降趋势,2009年趋缓。结论:我院消化系统用药基本合理,但基本药物使用须进一步提高,使药品应用和管理达到规范。 To investigate the utilization and tendency of digestive system essential drugs in our hospital and to provide reference for clinical use of drugs. METHODS : Adopting DDD analysis, the utilization of digestive system essential drugs in our hospital from 2007 to 2009 was analyzed in respect of amount of drugs, consumption sum, DDDs and DDC. RESULTS: The consumption sum of digestive system drugs in our hospital increased year after year, while the consumption sum of digestive system essential drugs showed a downward trend and decreased slowly in 2009. CONCLUSION: The utilization of digestive system drugs in our hospital is basically rational. But the utilization of essential drugs should be further improved to standard the application and management of drugs.
出处 《中国药房》 CAS CSCD 北大核心 2011年第12期1116-1119,共4页 China Pharmacy
关键词 消化系统 基本药物 用药频度 用药分析 Digestive system Essential drugs DDDs Analysis of drugs use
  • 相关文献

参考文献5

二级参考文献23

  • 1梁小燕,高青.质子泵抑制剂的研发进展[J].医学综述,2007,13(4):245-247. 被引量:22
  • 2Blanshard C, millson C, Sercombe J, et al.The effects of rabeprazole on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects[J].Gut, 1996, 39 (Suppl 3) :47.
  • 3Wilder-Smith CH, Rohhss K, Nilsson-Pieschl C, et al. Esomeprazole 40 mg provides improved intragastric acid control as compared with lansoprazole 30 mg and rabeprazole on human cytochrome P450 activities[J].DMD, 2004, 32(5):821.
  • 4Besancon M,Simon A,Sachsg,et al. Sites of reaction of the gastric H^+, K^+ -ATPase with extracytoplasmic thiol reagents[J]. Journal of Biological Chemistry, 1997, 272:22 438 - 22 446.
  • 5Lerang F, Mourn B, Hang JB, et al. Highly effective twice a day triple therapies for Helicobacter pylori infection and peptic ulcer disase: metronidazole resistance is of only minor importance [J]. Gastroenterology, 1996, 110: A173.
  • 6Welage LS, Berardi RR. Evaluation of Omeprazole. Lansopra - zole, Pantoprazole, in the treatment of acid related disease [ J ]. Jam Pharm Assoe Wash, 2000,40(1): 56 -62,121 - 123.
  • 7Mauch F, Bode G. Identification and characterization of an ATP ase system of Helicobacter pylori and the effect of proton pump inhibitors[J]. Am J Gastroenteml, 1993,88(10) : 1 801 - 1 802.
  • 8Varia D, A li A, GattaL, et al. Treatment of Helicobacter pylori[J]. Current Opinion Gastroenterology, 1998,14 Suppl 1 : 71S - 78S.
  • 9Smout AJ. Is the sensitivity to gastric acid inhibition Helicobacter pylori status dependent [ J ]. Scand J Gastroenterol, 1998,225 (Suppl) : 32.
  • 10Casbarrini A, Ojetti V, Pitocco D, et al. Efficacy of diferent Helicobacter pylori eradication regimens in patients affected by insul independent diabetes mellitus[ J]. Scand J Gastroenterol,2000, 35 (3) : 260 - 263.

共引文献39

同被引文献8

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部